Your search returned 5 results.

Results
	1.	New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2). [electronic resource] by Yki-Järvinen, Hannele Bergenstal, Richard Ziemen, Monika Wardecki, Marek Muehlen-Bartmer, Isabel Boelle, Emmanuelle Riddle, Matthew C Producer: 20150616 In: Diabetes care vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1). [electronic resource] by Garg, Satish K Wernicke-Panten, Karin Wardecki, Marek Kramer, Daniel Delalande, Francois Franek, Edward Sadeharju, Karita Monchamp, Travis Mukherjee, Bhaswati Shah, Viral N Producer: 20210122 In: Diabetes technology & therapeutics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial. [electronic resource] by Garg, Satish K Wernicke-Panten, Karin Wardecki, Marek Kramer, Daniel Delalande, Francois Franek, Edward Sadeharju, Karita Monchamp, Travis Miossec, Patrick Mukherjee, Bhaswati Shah, Viral N Producer: 20211014 In: Diabetes technology & therapeutics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial. [electronic resource] by Rosenstock, Julio Guerci, Bruno Hanefeld, Markolf Gentile, Sandro Aronson, Ronnie Tinahones, Francisco J Roy-Duval, Christine Souhami, Elisabeth Wardecki, Marek Ye, Jenny Perfetti, Riccardo Heller, Simon Producer: 20171030 In: Diabetes care vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes. [electronic resource] by Riddle, Matthew C Bolli, Geremia B Home, Philip D Bergenstal, Richard M Ziemen, Monika Muehlen-Bartmer, Isabel Wardecki, Marek Vinet, Laetitia Jeandidier, Nathalie Yki-Järvinen, Hannele Producer: 20161223 In: Diabetes technology & therapeutics vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)